Ritesh Gupta
Overview
Explore the profile of Ritesh Gupta including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
53
Citations
1592
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Ghosh A, Dutta K, Bhatt S, Gupta R, Tyagi K, Ansari I, et al.
J Clin Endocrinol Metab
. 2022 Mar;
107(6):e2267-e2275.
PMID: 35263436
Context: Excess hepatic and pancreatic fat may contribute to hyperglycemia. Objective: The objective of this study was to examine the effect of dapagliflozin (an SGLT2 inhibitor) on anthropometric profile, liver,...
2.
Gupta R, Kesavadev J, Krishnan G, Agarwal S, Saboo B, Shah M, et al.
Diabetes Metab Syndr
. 2021 Oct;
15(6):102322.
PMID: 34717135
Background And Aims: Mucormycosis is an invasive fungal infection and carries a significant morbidity and mortality. A number of cases of mucormycosis have been reported in association with COVID-19. In...
3.
Brar R, Gupta R, Gupta S, Chaudhary K, Singh P, Kaur M
J Pharm Bioallied Sci
. 2021 Aug;
13(Suppl 1):S72-S75.
PMID: 34447046
Background: Genioplasty has nowadays become a routine procedure in the correction of dentofacial deformities. The present study aimed to evaluate and compare the osseous and soft-tissue stability after advancement genioplasties,...
4.
Cristina do Vale Moreira N, Ceriello A, Basit A, Balde N, Mohan V, Gupta R, et al.
Diabetes Res Clin Pract
. 2021 Apr;
175:108823.
PMID: 33887353
Aims: We aimed to review insulin dosing recommendations, insulin regulation and its determinants, glycaemic response to carbohydrates, and the efficacy and safety of insulin therapy in different races/ethnicities. Methods: We...
5.
Misra A, Ghosh A, Gupta R
Diabetes Metab Syndr
. 2021 Feb;
15(1):403-406.
PMID: 33588198
Diabetes and hyperglycemia occurring during COVID-19 era have implications for COVID-19 related morbidity/mortality. In this brief review, we have attempted to categorise and classify such heterogenous hyperglycemic states. During COVID-19...
6.
Ghosh A, Anjana R, Shanthi Rani C, Jeba Rani S, Gupta R, Jha A, et al.
Diabetes Metab Syndr
. 2021 Jan;
15(1):215-220.
PMID: 33450530
Background And Aims: It is not known if new onset diabetes during Coronavirus-19 disease (COVID-19; NOD COVID) is phenotypically or biochemically different than new onset diabetes before COVID-19 (NOD). Methods:...
7.
Gupta R, Tyagi K, Anoop S, Ghosh A, Misra A
Diabetes Metab Syndr
. 2020 Dec;
14(6):2205-2210.
PMID: 33336647
Background And Aims: Asian Indian patients with type 2 diabetes mellitus (T2DM) have a high cardiovascular risk even at young age. There is a need to assess this increased risk...
8.
Gupta R, Misra A
Diabetes Metab Syndr
. 2020 Sep;
14(6):1777-1781.
PMID: 32942253
Background: Diabetes is recognized as an important comorbidity in patients with COVID-19 and a large amount of literature has become available regarding this. The aim of this article is to...
9.
Ghosh A, Arora B, Gupta R, Anoop S, Misra A
Diabetes Metab Syndr
. 2020 Jun;
14(5):917-920.
PMID: 32574982
Background And Aims: During the current pandemic of COVID-19, India is under lockdown which could cause disruption in diet and lifestyle in patients with type 2 diabetes (T2DM). We aimed...
10.
Gupta R, Misra A
Diabetes Res Clin Pract
. 2020 Jun;
165:108267.
PMID: 32533988
Despite a large population and limited health infrastructure, the incidence and mortality of Coronavirus Disease 2019 (COVID-19) has been lower in South Asia than many regions. The underlying reasons and...